Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 41% ± 11% | |
lung | 11 studies | 30% ± 11% | |
intestine | 9 studies | 26% ± 13% | |
brain | 6 studies | 30% ± 5% | |
kidney | 5 studies | 24% ± 4% | |
lymph node | 5 studies | 34% ± 10% | |
bone marrow | 4 studies | 28% ± 7% | |
eye | 4 studies | 22% ± 4% | |
uterus | 4 studies | 38% ± 12% | |
breast | 4 studies | 22% ± 2% | |
liver | 3 studies | 39% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7698.71 | 459 / 459 | 100% | 288.71 | 1118 / 1118 |
esophagus | 100% | 7239.21 | 1445 / 1445 | 100% | 173.27 | 183 / 183 |
intestine | 100% | 8290.92 | 966 / 966 | 100% | 250.24 | 527 / 527 |
ovary | 100% | 13839.77 | 180 / 180 | 100% | 182.08 | 430 / 430 |
pancreas | 100% | 6972.59 | 328 / 328 | 100% | 160.34 | 178 / 178 |
prostate | 100% | 6472.66 | 245 / 245 | 100% | 219.13 | 502 / 502 |
uterus | 100% | 10551.11 | 170 / 170 | 100% | 246.57 | 459 / 459 |
lung | 100% | 7027.64 | 577 / 578 | 100% | 201.04 | 1155 / 1155 |
bladder | 100% | 8219.38 | 21 / 21 | 100% | 205.48 | 503 / 504 |
thymus | 100% | 6745.10 | 653 / 653 | 100% | 177.63 | 603 / 605 |
stomach | 100% | 6916.69 | 359 / 359 | 100% | 224.06 | 285 / 286 |
skin | 100% | 9508.17 | 1809 / 1809 | 100% | 199.76 | 470 / 472 |
liver | 100% | 3884.60 | 226 / 226 | 100% | 130.19 | 404 / 406 |
kidney | 100% | 6059.19 | 89 / 89 | 99% | 156.84 | 891 / 901 |
brain | 98% | 3467.46 | 2595 / 2642 | 100% | 112.11 | 705 / 705 |
adrenal gland | 100% | 6859.15 | 258 / 258 | 97% | 100.33 | 224 / 230 |
adipose | 100% | 7718.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7556.94 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 213.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 333.50 | 29 / 29 |
muscle | 100% | 5206.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7357.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 176.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 63.05 | 1 / 1 |
peripheral blood | 98% | 8693.23 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 3941.05 | 826 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002183 | Biological process | cytoplasmic translational initiation |
GO_0001731 | Biological process | formation of translation preinitiation complex |
GO_0006413 | Biological process | translational initiation |
GO_0005850 | Cellular component | eukaryotic translation initiation factor 2 complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005525 | Molecular function | GTP binding |
GO_0008135 | Molecular function | translation factor activity, RNA binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0000049 | Molecular function | tRNA binding |
GO_1990856 | Molecular function | methionyl-initiator methionine tRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | EIF2S3 |
Protein name | Eukaryotic translation initiation factor 2 subunit gamma Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF2-gamma X) (eIF2gX) |
Synonyms | EIF2G |
Description | FUNCTION: Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA . This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form the 43S pre-initiation complex (43S PIC) (By similarity). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex (By similarity). In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (By similarity). . |
Accessions | ENST00000423068.1 P41091 ENST00000253039.9 H7BZU1 |